Scalp psoriasis.
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adults 18 to 65 years of age with a diagnosis of scalp psoriasis. Mild to moderate scalp psoriasis severity (determined by a standard scoring system)
Exclusion criteria
Exclusion criteria: Severe psoriasis (i.e. involving >10% of the body surface area). Use of other topical or systemic treatments in the past 4 weeks. Known hypersensitivity or contraindications to any of the components of the formulation, including Betamethasone or Coltarabine. The presence of other skin conditions that may interfere with the evaluation of scalp psoriasis. Pregnant and lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reducing the severity of scalp psoriasis symptoms. Timepoint: At the end of week 12, the reduction in symptom severity is measured. Method of measurement: Scalp psoriasis area and severity index. | — |
Secondary
| Measure | Time frame |
|---|---|
| Relief of patient-reported symptoms including itching, scaling, and redness. Timepoint: The rate of symptom recurrence is measured at weeks 4, 8, and 12. Method of measurement: Visual analog scale and dermatology quality of life index. | — |
Countries
Iran (Islamic Republic of)
Contacts
Yazd University of Medical Sciences